This finding was further supported by analysis of transcriptomic datasets of bladder tumors that showed significant MYC (mRNA) overexpression in bladder tumors harboring FGFR3 mutations, with MYC and FGFR3 expression levels being positively correlated, while in tumors bearing wildtype FGFR3, neither MYC overexpression nor such correlation was observed [91]. This evidence concerns the gene FGFR3 and urinary bladder neoplasm.